News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Chiron Dumps MeNZB Vaccine Trialled In NZ

Chiron Dumps MeNZB Vaccine Trialled In NZ


Barbara Sumner Burstyn & Ron Law

In a stunning vote of no-confidence in the MeNZB vaccine technology, Chiron (now called Novartis Vaccines) has announced the launch of clinical trials for a genetically engineered vaccine to fight meningococcal B disease.

In news reports of Chiron's new trials (See… Vaccine for the deadliest strain of meningitis – Daily Mail 7th November 2006), they say, "The development of a trial vaccine is being hailed as a major breakthrough. At present there are vaccines for [various bacteria], but a vaccine for the B strain of the disease has so far been elusive..."

No mention is made of the controversial experimental MeNZB vaccine trademarked to Chiron and used on over one million New Zealand children.

Mutation concerns

The Novartis Vaccines news release expresses concern that the meningococcal B bacteria can mutate, leading to the creation of several sub-strains. "Scientists have now been able to develop a vaccine that is effective against such mutations. Previously this problem had hindered them starting human trials," the release said.

When the MeNZB vaccine was first introduced Ministry of Health advisor and Chiron researcher Professor Keith Cartwright expressed concern about strain mutation. At that time the Ministry of Health denied that mutation was a possibility.

The meningococcal disease case fatality rate has increased by 250 percent since the MeNZB vaccine was rolled out resulting in 13 unexplained deaths.


Click for big version

Chiron Vaccines received well over $NZ100 million from the New Zealand taxpayer to broker, research and rollout the experimental MeNZB vaccine.

Data from the Ministry of Health reveals the MeNZB vaccine has had no impact on the levels of meningococcal disease in New Zealand, despite assurances to the contrary. (For evidence of the impact of MeNZB in New Zealand see MeNZB Facts Speak for Themselves – Scoop 1 November 2006)

Figures released last week reveal that Waikato children given the MeNZB vaccine actually have a higher risk of contracting meningococcal disease than unvaccinated children.

Since January 2005 all five deaths due to meningococcal disease in under twenty year olds have been in children vaccinated with MeNZB; not one unvaccinated child has died!

Meanwhile, despite the Norwegian government banning the export of over a million doses of their unsafe meningococcal B vaccine destined for France, 4,000 healthy babies are injected with the equivalent MeNZB toxin in New Zealand every week!

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>


Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>

ALSO:

Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION